Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil's National Immunization Program

Brendan Flannery1, Samia Samad, José Cássio de Moraes

  • 1US Centers for Disease Control and Prevention, Atlanta, GA 30333, United States. bflannery@cdc.gov

Vaccine
|January 15, 2013
PubMed

Insights

Brazil

Area of Science:

  • Public Health
  • Vaccinology
  • Epidemiology

Background:

  • Oral rotavirus vaccine introduced in Brazil in 2006 with age restrictions to mitigate intussusception risk.
  • Coverage for rotavirus vaccine (83%) lagged behind other infant immunizations (≥94%) years after introduction.

Purpose of the Study:

  • To analyze rotavirus vaccine uptake in Brazil.
  • To compare rotavirus vaccine coverage with diphtheria-tetanus-pertussis-Haemophilus influenzae type b vaccine (DTP-Hib) coverage.
  • To identify factors associated with lower rotavirus vaccine uptake.

Main Methods:

  • Analysis of national immunization program data on rotavirus vaccine (Rota1, Rota2) and DTP-Hib vaccine (DTP-Hib1, DTP-Hib2) coverage.
  • Comparison of coverage differences in 27 Brazilian cities in 2010.
  • Correlation of coverage gaps with delayed DTP-Hib vaccination.

Main Results:

  • In 2010, DTP-Hib1 coverage was 99.0% vs. Rota1 at 95.2%; DTP-Hib2 coverage was 98.4% vs. Rota2 at 83.0%.
  • Significant regional variations in coverage were observed.
  • Coverage gaps correlated with delayed DTP-Hib vaccination, suggesting age restrictions impacted rotavirus vaccine uptake.

Conclusions:

  • Age restrictions for rotavirus vaccination likely contributed to lower coverage.
  • Strategies to improve immunization timeliness are crucial for maximizing rotavirus vaccine benefits.
  • Continued monitoring of rotavirus vaccine uptake and intussusception risk is necessary.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...